Results 111 to 120 of about 61,922 (191)

Ebola opportunity [PDF]

Nature, 2014
openaire   +2 more sources

Perceptions of factors influencing Ebola vaccine acceptance among community members, healthcare workers, and response personnel in Eastern Democratic Republic of the Congo. [PDF]

PLoS One
Kallay R, Muhoza P, Tchoualeu DD, Fleming M, Garbern S, Makali SL, Perera SM, Fraterne-Muhayangabo R, Ombeni AB, Tuttle A, Aberle-Grasse E, Ortiz N, Doshi R, Levine AC, Mbong EN.   +14 more
europepmc   +1 more source

Confirming ERVEBO Vaccination to Support Ebola Virus Surveillance. [PDF]

Emerg Infect Dis
Karaaslan E, Whitesell A, Malenfant J, Carson WC, Townsend M, Jolie KK, Koivogui E, Grovogui SM, Diallo B, Gbamou N, Corvil S, Boumbaly S, Martel L, Sinclair JR, Camara A, Shoemaker T, Choi MJ, Montgomery JM, Spiropoulou CF, Bergeron É.   +19 more
europepmc   +1 more source

Risk behaviour associated with contracting the Ebola virus at funerals: a study of Liberians attending the funerals of individuals deceased from Ebola. [PDF]

Front Public Health
Stephens MT, Tangmunkongvorakul A, Kosashunhanan N, Fallah M, Gilayeneh JSM, Kie T, Srithanaviboonchai K.   +6 more
europepmc   +1 more source

Acceptability of the Ebola vaccine in the sub-Saharan African population: A systematic review and meta-analysis. [PDF]

BMC Infect Dis
Matangi B, Matondo P, Kayembe B, Okolo A, Tawaba D, Kinuka A, Mangala D, Odio O, Mayasi N, Lukiana T, Mandina M, Pindi T, Longokolo M, Mbula M, Situakibanza H, Bepouka B.   +15 more
europepmc   +1 more source

Marburg and Sudan virus outbreaks: are we any closer to a pan-filovirus vaccine? [PDF]

Trop Dis Travel Med Vaccines
Akingbola A, Adegbesan A, Adewole O, Olalude O, Isaiah O, Bhadmus F, Chuku J.   +6 more
europepmc   +1 more source

Ebola [PDF]

, 2019
Adel Elkady, Prabha Sinha, Soad Ali Zaki Hassan   +2 more
openaire   +2 more sources

Dual role of rVSV vectors in prophylactic and therapeutic innovation: a comprehensive bibliometric and clinical trial perspective. [PDF]

Front Immunol
Chen Y, Zhang Y, Zhang Y, Bie C, Wang R, Zhao Y, Lu M.   +6 more
europepmc   +1 more source

Somalia's Ebola preparedness and cross-border risk following the recent 2025 DRC outbreak. [PDF]

New Microbes New Infect
Ali AS, Ahmed MM.
europepmc   +1 more source

Development of VP30-targeted nanoparticles using DPS4 fusion peptides for the inhibition of Ebola virus. [PDF]

J Nanobiotechnology
Wu F, Huang Y, Li R, Gao P, Lv P, Wu G, Ma Y, Ding Q, Zhong J, Su J, Xu W.   +10 more
europepmc   +1 more source